Poxel S.A. (EPA:POXEL)
France · Delayed Price · Currency is EUR 0.2085
-0.0055 (-2.57%)
Jun 12, 2026, 5:35 PM CET
Poxel Market Cap
Poxel has a market cap or net worth of €11.5 million as of June 12, 2026. Its market cap has decreased by -69.95% in one year.
Market Cap
11.50M
Enterprise Value
71.45M
Revenue
7.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.21
Market Cap Chart
Since February 6, 2015, Poxel's market cap has decreased from 193.09M to 11.50M, a decrease of -94.05%. That is a compound annual growth rate of -22.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 11.50M | -8.55% |
| Dec 31, 2025 | 12.57M | 69.26% |
| Dec 31, 2024 | 7.43M | -61.80% |
| Dec 29, 2023 | 19.45M | -28.41% |
| Dec 30, 2022 | 27.16M | -80.72% |
| Dec 31, 2021 | 140.90M | -22.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nicox | 31.33M |
| genOway Société anonyme | 22.31M |
| GenSight Biologics | 19.18M |
| Advicenne | 16.35M |
| Aelis Farma | 15.15M |
| NFL Biosciences | 11.41M |
| Aton | 10.10M |
| TME Pharma | 7.71M |